Current Price Status
Stock is Shooting to the Moon
Stock is over-priced on the upper end by the market with the expectation of annual earning growth at 478.77% to match current price.
Stock in booming mode can be traded very volatile, price can swing largely day-to-day. While having big upside potential, the downside risk can be huge if the stock is not meeting the market expectation.
Company is not in Profit
- SUNZEN current price is 437.5% above OneDelta estimated fair value.
The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.
Relative Price Performance
UnderperformedSUNZEN past 5-day return lagged behind the Pharmaceuticals industry average return by 2.64%
Above 30-Day AverageCurrent price RM0.215 is above than 30-day average RM0.19 by 13.2%
Bank Analyst Price Targets
Revenue & Earning Growth Analysis
Potential Better Revenue Growth
SUNZEN posted a better revenue growth than average in the recent quarter.
Continued Losing Money
SUNZEN has been losing money in the 5 of the past 5 quarters.
Past Quarter Reports
|Quarter Date||Revenue (RM)||(%)||EPS (RM)||(%)|
Volume Trend Analysis
Recent Volume is Increasing
Surge in trading volume tends to bring more price volatility in near term.
SUNZEN recent daily traded volume is 175.76% higher than past month average.
|Past 30-Day||Past 5-Day|
|132k daily||364k daily|
Price History Chart
Past 30-day Average Price: RM0.19
Stock Fundamental Factors
Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.
Stocks that has more than two consecutive money-losing quarters
Stock Thematic Baskets
Usually the more the stock is included in popular themes, the more opportunity for price-driven momentum and better liquidity.
Stock Company Profile
SUNZEN BIOTECH BHD
Sunzen Biotech Bhd. is an investment holding company, which engages in the biotechnology research and development, manufacture, and marketing of animal feed supplement products. It operates through the Manufacturing and trading of animal health products, Trading and processing of crude palm oil and related products, Traditional Chinese medicines and herbal health foods and beverages, and Food ingredients products. The company was founded by Tan Kim Sing, Teo Kim Lai, Kok Poe Chu, and Fong Chan Seng on February 8, 2005 and is headquartered in Shah Alam, Malaysia.